Form 4: American Healthcare REIT Director Wilbur H. Smith III Receives Restricted Stock Grant Following Re-election

Wilbur H. Smith III, a director at American Healthcare REIT, Inc., was granted 3,042 shares of restricted common stock upon his re-election to the board, aligning his interests with shareholders.

Summary

• Wilbur H. Smith III, a Director of American Healthcare REIT, Inc. (AHR), was re-elected to the board of directors on June 25, 2025.
• Upon his re-election, Mr. Smith was granted 3,042 shares of restricted common stock.
• The granted shares of restricted common stock vest on June 25, 2026.
• Following this transaction, Mr. Smith beneficially owns a total of 32,419 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates continuity in governance and aligns director interests with shareholders, which is generally viewed favorably. It's a routine, expected event.

Positives

• The grant of restricted stock aligns the director's financial interests with those of the shareholders, encouraging long-term value creation.
• The re-election of Wilbur H. Smith III provides continuity and stability to the company's board of directors.

Negatives

• The granted shares are restricted and do not vest until June 25, 2026, meaning they are not immediately liquid for the director.

Risks

• The restricted common stock is subject to a vesting period, meaning the director must remain with the company until June 25, 2026, to fully realize the value of the grant.

Future Outlook

The granted restricted common stock is set to vest on June 25, 2026, indicating a future milestone for the director's equity compensation.

Industry Context

This transaction represents a routine equity compensation grant to a director in the real estate investment trust (REIT) sector, a common practice to incentivize long-term commitment and align management interests with shareholder returns.

Comparison to Industry Standards

• The practice of granting restricted stock to directors upon re-election is a standard compensation mechanism across various industries, including REITs, to foster long-term commitment and align interests.
• The specific number of shares granted would typically be benchmarked against peer companies within the healthcare REIT sector, considering the company's size, performance, and the director's role and tenure. Without specific peer data, a direct quantitative comparison is not possible from this document alone.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of restricted stock aligns the director's long-term interests with shareholder value creation, potentially leading to more focused decision-making for the company's benefit.

Next Steps

• The restricted common stock will vest on June 25, 2026, subject to the terms of the grant.

Key Dates

Keywords

American Healthcare REIT, AHR, SEC Form 4, Restricted Stock, Director Compensation, Equity Grant, Corporate Governance, Beneficial Ownership, Wilbur H. Smith III